Συγγραφείς:
Bonovas, S.
Filioussi, K.
Tsavaris, N.
Sitaras, N.M.
Λέξεις-κλειδιά:
hydroxymethylglutaryl coenzyme A reductase inhibitor; pravastatin, apoptosis; breast cancer; cancer incidence; cancer risk; cell invasion; chemoprophylaxis; clinical trial; drug activity; drug mechanism; follow up; human; laboratory test; letter; lipophilicity; meta analysis; priority journal; statistical significance; systematic review; treatment duration
